Literature DB >> 18674955

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer.

E Vairaktaris1, Z Serefoglou, D Avgoustidis, C Yapijakis, E Critselis, A Vylliotis, S Spyridonidou, S Derka, S Vassiliou, E Nkenke, E Patsouris.   

Abstract

Genetic association studies have implicated functional DNA polymorphisms in genes encoding factors related to angiogenesis, inflammation and thrombosis with increased risk for oral squamous cell carcinoma (OSCC). This study examines possible interactions between nine such genotype polymorphisms and their combinatory effect in assessing the OSCC risk in a European population. OSCC cases (N=162) and healthy controls (N=168) of comparable age, gender, and ethnicity (Greeks and Germans) were studied. Multivariate logistic regression models were constructed in order to assess the contribution of homozygous or heterozygous variant genotypes of polymorphisms MMP-1 (-1607 1G/2G), MMP-3 (-1171 5A/6A), MMP-9 (-1562C/T), TIMP-2 (-418C/G), VEGF (+936C/T), GPI-alpha (+807C/T), PAI-1 (4G/5G), ACE (intron 16D/I) and TAFI (+325C/T) upon overall, early and advanced stages of OSCC. Four out of nine polymorphisms affecting PAI-1, MMP-9, TIMP-2 and ACE expression contributed significantly in OSCC prediction in the various logistic regression models. Based on these findings and previous reports, possible interactions of the implicated factors leading to OSCC development, as well as an algorithm of risk estimation are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674955     DOI: 10.1016/j.oraloncology.2008.05.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals.

Authors:  Wei-Dong Leng; Mei-Ni He; Qi-Lin Chen; Heng Gong; Li Zhang; Xian-Tao Zeng
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

2.  Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.

Authors:  Li-Feng Zhang; Yuan-Yuan Mi; Qiang Cao; Wei Wang; Chao Qin; Jun-Feng Wei; Yao-Jun Zhou; Yong-Fei Li; Min Tang; Wei-Min Liu; Wei Zhang; Jian-Gang Zou
Journal:  Mol Biol Rep       Date:  2011-06-30       Impact factor: 2.316

3.  The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.

Authors:  Yonggang Zhang; Jie He; Yao Deng; Jie Zhang; Xiaobo Li; Zhangpeng Xiang; Honglang Huang; Can Tian; Jin Huang; Hong Fan
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

4.  Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Authors:  Paul R Gard
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-20

5.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

6.  Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.

Authors:  Cheng-Hsi Liao; Chia-Wen Tsai; Wen-Shin Chang; Zhi-Hong Wang; Chi-Li Gong; Hsi-Chin Wu; Bo-Ren Wang; Shih-Wei Hsu; Wen-Chin Huang; Te-Chun Shen; DA-Tian Bau
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

Review 7.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

Review 8.  Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.

Authors:  Xiaoying Li; Lianxi Qu; Yu Zhong; Yingjie Zhao; Hongyan Chen; Lu Daru
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-05       Impact factor: 4.553

9.  An updated meta-analysis on association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer risk.

Authors:  Yuebing Xie; Chao You; Jing Chen
Journal:  Tumour Biol       Date:  2014-04-03

10.  PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.

Authors:  Shangqian Wang; Qiang Cao; Xiaoxiang Wang; Bingjie Li; Min Tang; Wanqing Yuan; Jianzheng Fang; Jian Qian; Chao Qin; Wei Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.